Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Annaelle Soubieux1, Caroline Plante2, Johann-François Ouellette-Frève3

  • 1travaille à l'Unité de recherche en pratique pharmaceutique, Département de pharmacie, Centre hospitalier universitaire Sainte-Justine, Montréal (Québec). Elle est aussi candidate au D. Pharm. à l'Université Paris Descartes.

The Canadian Journal of Hospital Pharmacy
|February 29, 2020
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical Methods for the Quantification of Drugs and Their Metabolites in Human Hair: A Systematic Review From 2010 to 2025.

Drug testing and analysis·2026
Same author

Unsolicited Email and Predatory Solicitations: A Retrospective Case Study of a Canadian Hospital Pharmacist and the Tip of a Larger Iceberg.

The Canadian journal of hospital pharmacy·2026
Same author

[Observatory of scientific publications by Quebec pharmacists: An exploratory survey].

Annales pharmaceutiques francaises·2026
Same author

Novel Genetic Risk Factor Identified for L-Asparaginase-Induced Pancreatitis in Pediatric Patients With Cancer.

Pediatric blood & cancer·2026
Same author

[Profile of training courses offered in clinical pharmacy in hospitals: An exploratory North-South study].

Annales pharmaceutiques francaises·2026
Same author

Survey of Guidance for Authors on the Use of Generative Artificial Intelligence in Pharmaceutical Journals.

The Canadian journal of hospital pharmacy·2026
Same journal

Canadian Healthcare-Systems Pharmacy Residency Graduates/Diplômés de Programmes Canadiens de Résidence en Pharmacie dans les Réseaux de la Santé.

The Canadian journal of hospital pharmacy·2026
Same journal

From Project to Publication: A Decade of Pharmacy Residency Research in the British Columbia Lower Mainland (2011/12-2020/21).

The Canadian journal of hospital pharmacy·2026
Same journal

Eligibility, Participation, and Matching Outcomes of International Pharmacy Graduates in Accredited Pharmacy Residency Programs in Canada: A Policy Scan and Cross-Sectional Analysis.

The Canadian journal of hospital pharmacy·2026
Same journal

A Farewell to Readers.

The Canadian journal of hospital pharmacy·2026
Same journal

The Canadian journal of hospital pharmacy·2026
Same journal

Defining Optimal Pharmacist-to-Patient Ratios for Comprehensive Direct Patient Care in Pediatric Settings: A Nationwide Survey in Canada.

The Canadian journal of hospital pharmacy·2026
See all related articles
This summary is machine-generated.

Using closed-system drug transfer devices (CSTDs) for preparing antineoplastic medications increases supply costs compared to traditional methods. This analysis highlights the financial implications for healthcare facilities in Canada.

Area of Science:

  • Oncology
  • Health Economics
  • Pharmacy Practice

Context:

  • Healthcare workers face risks from hazardous drug exposure.
  • Standard practices for preparing and administering antineoplastics exist.
  • Closed-system drug transfer devices (CSTDs) are an alternative to traditional methods.

Purpose:

  • To compare the supply costs of preparing one intravenous dose of antineoplastic drugs.
  • To evaluate costs between traditional methods and using a CSTD in a Canadian adult healthcare facility.

Summary:

  • A cost analysis examined supply expenses for antineoplastic IV dose preparation.
  • Traditional systems cost $9.89-$22.37 per dose.
  • CSTD systems cost $12.34-$64.19 per dose, representing an annual increase of $363,566 to $1,238,072.
Keywords:
administrationclosed-system drug transfer devicehazardous drugpreparation

Related Experiment Videos

Impact:

  • CSTDs significantly increase the cost of supplies for antineoplastic drug preparation.
  • Healthcare decision-makers must analyze costs and consequences for informed choices.
  • This study provides original data on the financial impact of CSTD use in antineoplastic administration.